Precision Oncology Clinical Trials: A Systematic Review of Phase II Clinical Trials with Biomarker-Driven, Adaptive Design.

MLA

Ha, Hyerim, et al. “Precision Oncology Clinical Trials: A Systematic Review of Phase II Clinical Trials with Biomarker-Driven, Adaptive Design.” Cancer Research and Treatment, vol. 56, no. 4, Oct. 2024, pp. 991–1013. EBSCOhost, https://doi.org/10.4143/crt.2024.128.

APA

Ha, H., Lee, H. Y., Kim, J. H., Kim, D. Y., An, H. J., Bae, S., Park, H.-S., & Kang, J. H. (2024). Precision Oncology Clinical Trials: A Systematic Review of Phase II Clinical Trials with Biomarker-Driven, Adaptive Design. Cancer Research and Treatment, 56(4), 991–1013. https://doi.org/10.4143/crt.2024.128

Chicago

Ha, Hyerim, Hee Yeon Lee, Jee Hyun Kim, Do Yeun Kim, Ho Jung An, SeungJin Bae, Hye-Sung Park, and Jin Hyoung Kang. 2024. “Precision Oncology Clinical Trials: A Systematic Review of Phase II Clinical Trials with Biomarker-Driven, Adaptive Design.” Cancer Research and Treatment 56 (4): 991–1013. doi:10.4143/crt.2024.128.